Data / Federal grants / HT942526BCRPBTA122
DoW Breast Cancer, Breakthrough Award Levels 1 and 2
Defense Health Agency Contracting Activity - DHACA (Department of Defense) is accepting applications until November 18, 2026. It lists 6 awards expected, $10.6 million in total.
SpecStream is the live web data engine for teams and agents. It reads every open and forecast federal opportunity on Grants.gov each morning, and this page is that reading. Describe your organization once and the grants that fit arrive in your sheet, CRM, Slack or agent as they are posted.
Key facts
- Opportunity number
- HT942526BCRPBTA122
- Status
- Posted, open
- Posted
- September 3, 2026
- Closes
- November 18, 2026
- Expected awards
- 6
- Total funding
- $10,600,000
- Cost sharing
- Not required
- Funding instrument
- Grant
- Category
- Science and Technology and other Research and Development
- Assistance listing
- 12.420 Military Medical Research and Development
- Contact
- Danielle Reckley Grantor · [email protected] · 301-619-1139
Who can apply
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
What the agency says
Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. Applications must address the challenge in a way that can lead to a breakthrough and have major impact. The FY26 Breakthrough Award mechanism contains four different funding levels designed to support major (but not all) stages of research that will lead to clinical application. Each level specifies a distinct research scope. This program announcement discusses the Breakthrough Award Levels 1 and 2.
Distinctive Features:
* This funding mechanism allows for applications submitted under Funding Level 1 or Funding Level 2. Funding Level 2 also includes a Population Science Studies option. With compelling justification, population science studies may request higher levels of funding and an additional year in the period of performance.
* This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, failure to submit all associated (Initiating and Partnering PI) applications by the deadline may result in administrative withdrawal.
Other open grants from the Department of Defense
| Opportunity | Status | Closes | Award ceiling | Total funding | Record |
|---|---|---|---|---|---|
| ONR FY27 NOFO for Young Investigator Program N0001426SF004 | Open | Oct 30 | grants.gov | ||
| DoW Bone Marrow Failure, Idea Development Award HT942526BMFRPIDA | Open | Nov 4 | $4,000,000 | grants.gov | |
| DoW Bone Marrow Failure, Investigator-Initiated Research Award HT942526BMFRPIIRA | Open | Nov 4 | $1,250,000 | grants.gov | |
| DoW Bone Marrow Failure, Resource Development Award HT942526BMFRPRDA | Open | Nov 4 | $1,250,000 | grants.gov | |
| DoW Reconstructive Transplant, Concept Award HT942526RTRPCA | Open | Nov 4 | $600,000 | grants.gov | |
| DoW Reconstructive Transplant, Investigator-Initiated Research Award HT942526RTRPIIRA | Open | Nov 4 | $8,000,000 | grants.gov |
All grants open to Anyone (unrestricted) · Everything closing in November 2026
Read from the Grants.gov API, last updated 2026-10-24. The agency's notice on Grants.gov is the official record; check it before you apply.